RGLS
Regulus Therapeutics
RGLS
RGLS
Delisted
RGLS was delisted on the 24th of June, 2025.
27 hedge funds and large institutions have $2.44M invested in Regulus Therapeutics in 2018 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
57% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 14
93% less capital invested
Capital invested by funds: $35.1M → $2.44M (-$32.6M)
Holders
27
Holding in Top 10
–
Calls
$5K
Puts
$4K
Top Buyers
1 | +$103K | |
2 | +$22.4K | |
3 | +$21K | |
4 |
WS
Wedbush Securities
Los Angeles,
California
|
+$18.1K |
5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$11.3K |
Top Sellers
1 | -$4.03M | |
2 | -$783K | |
3 | -$97K | |
4 |
BI
BVF Inc
San Francisco,
California
|
-$82.4K |
5 |
SDIC
South Dakota Investment Council
Sioux Falls,
South Dakota
|
-$73K |